NCT07117162 Improving Access to Care for Veterans With Memory Loss
| NCT ID | NCT07117162 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Pittsburgh Healthcare System |
| Condition | Alzheimer Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-10-29 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-10-29 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score \>7 * Meets VA MUE inclusion/exclusion criteria for mAb therapy for AD * Enrolled in VA care * Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital) * Has a working telephone * 18 years and older * Able to communicate in English * Willing to give informed consent. Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07117162 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07117162 currently recruiting?
Yes, NCT07117162 is actively recruiting participants. Contact the research team at alison.odonnell2@va.gov for enrollment information.
Where is the NCT07117162 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT07117162 clinical trial?
NCT07117162 is sponsored by VA Pittsburgh Healthcare System. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.